French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies
Vincent Lavoue,
Amélia Favier,
Sophie FRANCK,
Gérard Boutet,
Anne-Sophie Azuar,
Susie Brousse,
François Golfier,
Catherine Uzan,
Charlotte Vaysse,
Sébastien Molière,
Martine Boisserie-Lacroix,
Edith Kermarrec,
Jean-Yves Seror,
Yann Delpech,
Élisabeth Luporsi,
Christine M. Maugard,
Nicolas Taris,
Nathalie Chabbert-Buffet,
Jonathan Sabah,
Khalid Alghamdi,
Xavier Fritel,
Carole Mathelin
Affiliations
Vincent Lavoue
CHU Service de Gynécologie, 16 Boulevard de Bulgarie, 35200, Rennes, France
Amélia Favier
Gynécologie-obstétrique et Médecine de La Reproduction, Maternité Hôpital Tenon, 4 Rue de La Chine, 75020, Paris, France
Sophie FRANCK
Institut Curie, 26 Rue D'Ulm, 75248, Paris Cedex 05, France
Gérard Boutet
AGREGA, Service de Chirurgie Gynécologique et Médecine de La Reproduction, Centre Aliénor D’Aquitaine, Centre Hospitalier Universitaire de Bordeaux, Groupe Hospitalier Pellegrin, Place Amélie-Raba-Léon, 33000, Bordeaux, France
Anne-Sophie Azuar
Centre Hospitalier Clavary, Chemin de Clavary, 06130, Grasse, France
Susie Brousse
Service D'oncologie Chirurgicale, Centre Eugène Marquis, Unicancer, Rennes, France
François Golfier
Service de Chirurgie Gynécologique et Cancérologique - Obstétrique, Hospices Civils de Lyon, CHU Lyon Sud, Lyon, France
Catherine Uzan
Hôpital Pitié Salpetrière, 47 Bld de L'Hôpital, 75013, Paris, France
Charlotte Vaysse
Service de Chirurgie Oncologique, CHU Toulouse, Institut Universitaire Du Cancer de Toulouse-Oncopole, 1 Avenue Irène Joliot Curie, 31059, Toulouse, France
Sébastien Molière
Imagerie Du Sein, CHRU, Avenue Molière, 67200, Strasbourg, France
Martine Boisserie-Lacroix
Unité de Radiologie-sénologie. Institut Bergonié, 229 Cours de L'Argonne, 33000, Bordeaux, France
Edith Kermarrec
Hôpital Tenon Service de Radiologie, 4 Rue de La Chine, 75020, Paris, France
Jean-Yves Seror
Imagerie Duroc, 9 Ter Boulevard Montparnasse 75006 Paris, France
Yann Delpech
Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189, Nice, France
Élisabeth Luporsi
Oncologie Médicale et Oncogénétique, CHR Metz-Thionville, Hôpital de Mercy, 1 Allée Du Château, 57085, Metz, France
Christine M. Maugard
Service de Génétique Oncologique Clinique et Unité de Génétique Oncologique Moléculaire, Hôpitaux Universitaires de Strasbourg, 1 Avenue Molière, 67200, Strasbourg, France
Nicolas Taris
Service de Génétique Oncologique, ICANS, 17 Rue Calmette, 67200, Strasbourg, France, France
Nathalie Chabbert-Buffet
Hôpital Tenon Service de Gynécologie-obstétrique, 4 Rue de La Chine, 75020, Paris, France
Jonathan Sabah
CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France
Khalid Alghamdi
CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France
Xavier Fritel
Centre Hospitalo-universitaire de Poitiers, 2 Rue de La Milétrie, 86021, Poitiers, France
Carole Mathelin
CHRU Avenue Molière, 67200, Strasbourg et ICANS, 17 Rue Albert Calmette, 67033, Strasbourg,Cedex, France; Corresponding author.ICANS 17 rue Albert Calmette, 67033, Strasbourg cedex, France
Breast cancer is the most common female cancer in the world. Numerous studies have shown that the risk of metastatic disease increases with tumor volume. In this context, it is useful to assess whether the regular practice of formal breast self-examination (BSE) as opposed to breast awareness has an impact on the number of cancers diagnosed, their stage, the treatments used and mortality. Design: The Commission of Senology (CS) of the Collège National de Gynécologie et Obstétrique Français (CNGOF) respected and followed the Grading of Recommendations Assessment, Development and Evaluation method to assess the quality of the evidence on which the recommendations were based. Methods: The CS studied 16 questions individualizing four groups of women (general population, women aged over 75, high-risk women, and women previously treated for breast cancer). For each situation, it was determined whether the practice of BSE versus abstention from this examination led to detection of more breast cancers and/or recurrences and/or reduced treatment and/or increased survival. Results: BSE should not be recommended for women in the general population, who otherwise benefit from clinical breast examination by practitioners from the age of 25, and from organized screening from 50 to 74 (strong recommendation). In the absence of data on the benefits of BSE in patients aged over 75, for those at high risk and those previously treated for breast cancer, the CS was unable to issue recommendations. Thus, if women in these categories wish to undergo BSE, information on the benefits and risks observed in the general population must be given, notably that BSE is associated with a higher number of referrals, biopsies, and a reduced quality of life.